Gossamer Bio Inc at Barclays Global Healthcare Conference Transcript
Good afternoon. Welcome to the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. I am pleased to welcome Gossamer Bio to the stage.
Gossamer has got a catalyst-filled 2022 with a UC readout coming up in the not-too-distant future, and some PAH data potentially in the back half of the year. We've got a number of people from the company today.
We've got Bryan Giraudo, COO, CFO. You've got another title every other quarter. Richard Aranda, CMO; and Robert Roscigno, who runs the PAH program. Guys, thank you very much for joining us today.
Thank you for having us, Carter. And thanks to the Barclays organization. Great to be back in person.
Maybe before we get started, Bryan, I might just ask you to make just a couple of opening comments around the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |